Business news digest for November 16
SMMT•
SMMT•The digest says the FDA reportedly rejected Summit Therapeuticals’ cancer drug, Megaspeed reportedly said Alice Huang left in August 2025, and Commerce Secretary Howard Lutnick reportedly pushed to weaken chip rules.
The FDA reportedly rejected Summit Therapeuticals’ first-of-its-kind cancer drug, which was invented in China, because the results included patients who had already undergone chemotherapy.
Megaspeed reportedly said publicly for the first time on Sunday that Alice Huang, described as an alleged Chinese spy and linked to Nvidia’s former CEO Jensen, left the company in August 2025.
Commerce Secretary Howard Lutnick reportedly pushed to weaken chip rules to avoid a conflict-of-interest situation. He previously headed Cantor Fitzgerald, which controls a Malaysian data center set up to supply computing power to a Chinese technology firm.


